Novel findings shed light on the role of tumor necrosis factor in ankylosis and inflammation, pointing to new indications for blockade of this cytokine in treating spondyloarthritis. At the same time, the identification of other potential targets for therapy could expand the treatment options for this family of inflammatory disorders.
